0001214659-22-004373.txt : 20220325 0001214659-22-004373.hdr.sgml : 20220325 20220325175118 ACCESSION NUMBER: 0001214659-22-004373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220323 FILED AS OF DATE: 20220325 DATE AS OF CHANGE: 20220325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOORE ALISON CENTRAL INDEX KEY: 0001754937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 22772697 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-55852.xml PRIMARY DOCUMENT X0306 4 2022-03-23 0001737287 Allogene Therapeutics, Inc. ALLO 0001754937 MOORE ALISON 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Technical Officer Stock Option (Right to Buy) 9.69 2022-03-23 4 A false 737179 0.00 A 2032-03-23 Common Stock 737179 737179 D 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter. /s/ Veer Bhavnagri, Attorney-in-Fact for Alison Moore 2022-03-25